Integrated Advisors Network’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $926K | Sell |
2,080
-76
| -4% | -$33.8K | 0.04% | 371 |
|
|
2025
Q1 | $1.05M | Sell |
2,156
-924
| -30% | -$448K | 0.05% | 310 |
|
|
2024
Q4 | $1.24M | Sell |
3,080
-673
| -18% | -$271K | 0.06% | 271 |
|
|
2024
Q3 | $1.75M | Buy |
3,753
+381
| +11% | +$177K | 0.08% | 228 |
|
|
2024
Q2 | $1.58M | Buy |
3,372
+727
| +27% | +$341K | 0.08% | 226 |
|
|
2024
Q1 | $1.11M | Buy |
2,645
+683
| +35% | +$285K | 0.06% | 289 |
|
|
2023
Q4 | $798K | Buy |
1,962
+153
| +8% | +$62.3K | 0.05% | 323 |
|
|
2023
Q3 | $629K | Buy |
1,809
+9
| +0.5% | +$3.13K | 0.04% | 361 |
|
|
2023
Q2 | $633K | Buy |
1,800
+104
| +6% | +$36.6K | 0.04% | 375 |
|
|
2023
Q1 | $534K | Buy |
1,696
+46
| +3% | +$14.5K | 0.03% | 412 |
|
|
2022
Q4 | $476K | Sell |
1,650
-562
| -25% | -$162K | 0.03% | 426 |
|
|
2022
Q3 | $640K | Sell |
2,212
-52
| -2% | -$15K | 0.04% | 347 |
|
|
2022
Q2 | $638K | Sell |
2,264
-9
| -0.4% | -$2.54K | 0.04% | 366 |
|
|
2022
Q1 | $593K | Buy |
2,273
+310
| +16% | +$80.9K | 0.03% | 401 |
|
|
2021
Q4 | $431K | Buy |
1,963
+302
| +18% | +$66.3K | 0.03% | 443 |
|
|
2021
Q3 | $301K | Buy |
1,661
+208
| +14% | +$37.7K | 0.02% | 512 |
|
|
2021
Q2 | $293K | Sell |
1,453
-1,019
| -41% | -$205K | 0.02% | 484 |
|
|
2021
Q1 | $531K | Buy |
2,472
+441
| +22% | +$94.7K | 0.05% | 321 |
|
|
2020
Q4 | $480K | Buy |
2,031
+281
| +16% | +$66.4K | 0.05% | 288 |
|
|
2020
Q3 | $476K | Buy |
1,750
+266
| +18% | +$72.4K | 0.06% | 262 |
|
|
2020
Q2 | $430K | Buy |
1,484
+309
| +26% | +$89.5K | 0.05% | 278 |
|
|
2020
Q1 | $280K | Buy |
+1,175
| New | +$280K | 0.05% | 289 |
|